Primary |
Hypertension |
52.8% |
Back Pain |
7.0% |
Depression |
6.3% |
Anaesthesia |
4.2% |
Cardiovascular Event Prophylaxis |
2.8% |
Chronic Obstructive Pulmonary Disease |
2.8% |
Essential Hypertension |
2.8% |
Gastrooesophageal Reflux Disease |
2.8% |
Blood Pressure Abnormal |
2.1% |
Diabetes Mellitus |
2.1% |
Hypercholesterolaemia |
2.1% |
Anxiety |
1.4% |
Anxiety Disorder |
1.4% |
Cardiac Failure |
1.4% |
Dementia Alzheimer's Type |
1.4% |
Hiatus Hernia |
1.4% |
Musculoskeletal Pain |
1.4% |
Prostate Cancer |
1.4% |
Thrombosis Prophylaxis |
1.4% |
Anticoagulant Therapy |
0.7% |
|
Renal Failure Acute |
14.0% |
Hypokalaemia |
10.0% |
Dizziness |
8.0% |
Gout |
6.0% |
Overdose |
6.0% |
Palpitations |
6.0% |
Abdominal Pain |
4.0% |
Anaphylactic Shock |
4.0% |
Atrioventricular Block Complete |
4.0% |
Blood Pressure Increased |
4.0% |
Haemoptysis |
4.0% |
Hyponatraemia |
4.0% |
Knee Arthroplasty |
4.0% |
Malaise |
4.0% |
Sopor |
4.0% |
Syncope |
4.0% |
Vomiting |
4.0% |
Adverse Drug Reaction |
2.0% |
Adverse Event |
2.0% |
Anxiety |
2.0% |
|
Secondary |
Hypertension |
31.9% |
Back Pain |
14.9% |
Drug Use For Unknown Indication |
14.2% |
Product Used For Unknown Indication |
14.2% |
Essential Hypertension |
7.5% |
Atrial Fibrillation |
2.7% |
Ill-defined Disorder |
2.4% |
Rheumatoid Arthritis |
1.7% |
Arrhythmia |
1.4% |
Blood Pressure |
1.4% |
Type 2 Diabetes Mellitus |
1.4% |
Dementia Alzheimer's Type |
1.0% |
Osteoarthritis |
1.0% |
Blood Pressure Abnormal |
0.7% |
Depression |
0.7% |
Diabetes Mellitus |
0.7% |
Ear Disorder |
0.7% |
Headache |
0.7% |
Hypercholesterolaemia |
0.7% |
Asthma |
0.3% |
|
Completed Suicide |
12.5% |
Overdose |
10.9% |
Renal Failure Acute |
9.4% |
Syncope |
9.4% |
Retroperitoneal Fibrosis |
7.8% |
Urinary Tract Infection |
6.3% |
Dizziness |
4.7% |
Hyponatraemia |
4.7% |
Blood Pressure Increased |
3.1% |
Bradycardia |
3.1% |
Cardio-respiratory Arrest |
3.1% |
Drug Ineffective |
3.1% |
Oedema Peripheral |
3.1% |
Orthostatic Hypotension |
3.1% |
Skin Laceration |
3.1% |
Sopor |
3.1% |
Toxicity To Various Agents |
3.1% |
Vomiting |
3.1% |
Asthma |
1.6% |
Cardiac Arrest |
1.6% |
|
Concomitant |
Drug Use For Unknown Indication |
20.9% |
Hypertension |
17.0% |
B-cell Lymphoma |
10.8% |
Product Used For Unknown Indication |
10.0% |
Diffuse Large B-cell Lymphoma |
6.4% |
Depression |
5.5% |
Pain |
5.2% |
Rheumatoid Arthritis |
4.3% |
Blood Cholesterol Increased |
3.3% |
Type 2 Diabetes Mellitus |
2.9% |
Back Pain |
2.0% |
Dyspepsia |
2.0% |
Osteoporosis |
1.7% |
Anxiety |
1.4% |
Blood Pressure |
1.1% |
Nausea |
1.1% |
Smoking Cessation Therapy |
1.1% |
Prophylaxis |
1.1% |
Sleep Disorder |
1.1% |
Hepatitis C |
1.0% |
|
Weight Decreased |
10.4% |
Vaginal Haemorrhage |
9.2% |
Vomiting |
9.2% |
Dehydration |
7.5% |
Oral Candidiasis |
6.9% |
Pancreatitis Acute |
6.4% |
Weight Increased |
5.8% |
Shock |
4.6% |
Thrombocytopenia |
4.6% |
Urticaria |
4.6% |
Myocardial Infarction |
4.0% |
Urinary Tract Infection |
4.0% |
Pain In Extremity |
3.5% |
Death |
2.9% |
Headache |
2.9% |
Hypotension |
2.9% |
Inappropriate Antidiuretic Hormone Secretion |
2.9% |
Pharmaceutical Product Complaint |
2.9% |
Presyncope |
2.3% |
Rash |
2.3% |
|
Interacting |
Hypertension |
66.7% |
Diabetes Mellitus |
33.3% |
|
Bradycardia |
20.0% |
Electrocardiogram Qt Interval |
20.0% |
Hypochloraemia |
20.0% |
Hypokalaemia |
20.0% |
Hypoxic-ischaemic Encephalopathy |
20.0% |
|